A recent legislative enactment introduces specialized borrowing thresholds for various graduate programs. Presently, federal loan limits for graduate students do not differentiate based on their field of study. However, under the updated provisions, annual limits for unsubsidized loans will remain constant at $20,500 for general graduate programs, while professional students pursuing fields like medicine, dentistry, or law will see their annual borrowing capacity increase to $50,000.
Significant adjustments are also being made to the cumulative loan amounts students can incur throughout their graduate education. Currently, all graduate students face a uniform lifetime borrowing cap of $138,500. Beginning in July 2026, this will be recalibrated, with a new total limit of $100,000 for unsubsidized loans for general graduate students. Conversely, professional students will benefit from a higher overall limit of $200,000. It is also important to note that, for both graduate and professional students, the availability of PLUS loans and subsidized loans will be discontinued.
The new bill grants tertiary educational institutions the autonomy to impose reduced yearly loan maximums for both undergraduate and graduate students, tailored to specific fields of study. Furthermore, a comprehensive lifetime aggregate borrowing cap of $257,500 has been established, applicable across all levels of study, including undergraduate, graduate, and doctoral programs. For students enrolled on a less than full-time basis, defined as fewer than 24 credit hours, a revised calculation method will determine their borrowing eligibility. This new formula will directly link the amount a student can borrow to the number of credits they are pursuing. For instance, an undergraduate student enrolling for only 12 credit hours in an academic year will only be able to access half of their otherwise available loan amount. Additionally, annual limits for Parent PLUS loans, designed to assist parents with their child's educational expenses, will be capped at $20,000, with a new overall aggregate limit of $65,000. These limits represent a departure from previous policies, which allowed borrowing amounts to fluctuate based on institutional attendance costs and a child's financial aid package.
The Clorox Company has formally accused its long-term IT services partner, Cognizant Technology Solutions, of profound negligence and a serious breach of their contractual obligations. This accusation follows a damaging cyber incident that is estimated to have cost Clorox approximately $380 million in total, encompassing remediation expenses and significant business interruptions.
For more than a decade, Clorox entrusted Cognizant with the critical function of managing its employee service desk. This included sensitive operations such as password recovery and credential resets. A fundamental tenet of their agreement stipulated that no credentials would be reset without a stringent authentication process for the requesting party. However, Clorox contends that Cognizant repeatedly failed to adhere to these vital procedures, directly leading to the security compromise.
On August 11, 2023, a cybercriminal reportedly exploited these vulnerabilities. Clorox alleges that Cognizant's service desk granted the attacker direct access to Clorox's network credentials without any proper verification. Recorded conversations supposedly show a Cognizant agent explicitly providing a password to the cybercriminal without authentication. This critical lapse allowed unrestricted access to Clorox's systems, initiating a widespread attack.
The cyberattack had catastrophic consequences for Clorox. Its corporate network was severely crippled, supply chains were disrupted, and the company's ability to fulfill orders was significantly impaired. Beyond the initial impact, Clorox claims that Cognizant's subsequent incident response and disaster recovery efforts were mismanaged, exacerbating the overall damage. The total cost to Clorox included over $49 million in direct recovery expenses, alongside hundreds of millions in lost business due to operational paralysis.
In response to Clorox's claims, a Cognizant spokesperson issued a statement asserting that Clorox's internal cybersecurity system was inept and that Cognizant's role was limited to help desk services, which were, in their view, reasonably performed. Cognizant maintained that it was not responsible for Clorox's overall cybersecurity management. Despite the significant impact on Clorox, Cognizant reported robust revenues of $20 billion in 2024, seemingly unaffected by the controversy or associated reputational damage.
AB InBev, the prominent global brewing entity, faced headwinds in its second-quarter operations, as both revenue and sales volumes did not meet anticipated figures. This performance dip was primarily influenced by diminished consumer interest in China and Brazil. Despite these regional challenges, the company maintained an optimistic outlook for the remainder of the year, suggesting a strategic confidence in its recovery and long-term objectives.
The financial results revealed a complex picture of global market dynamics. While certain regions struggled, others demonstrated resilience, showcasing the diverse nature of AB InBev's market footprint. The company's leadership highlighted the effectiveness of its ongoing strategies in achieving satisfactory first-half results, which forms the basis of their continued positive projections for the fiscal year.
Anheuser-Busch InBev, the world's largest brewing company and owner of iconic brands such as Budweiser and Michelob, reported a challenging second quarter. Shares experienced a significant drop following the announcement of weaker-than-anticipated sales volumes and revenue. The primary culprits behind this underperformance were identified as sluggish demand in crucial markets like China and Brazil. Overall, the company's total volume saw a 1.9% decrease, with beer volume specifically declining by 2.2%. This dip contrasted sharply with analyst expectations for revenue, which fell short of the $15.28 billion forecast, despite adjusted earnings per share (EPS) of $0.98 aligning closely with predictions.
The second-quarter figures presented a mixed bag for AB InBev. While adjusted earnings per share reached $0.98, meeting market expectations, the company's revenue of $15.00 billion missed the Visible Alpha consensus of $15.28 billion. More concerning was the volume performance, which recorded a 1.9% decline to 143.3 million hectoliters, falling below projections. This decline was particularly pronounced in beer sales, which saw a 2.2% reduction, though non-beer volume showed a marginal increase of 0.3%. These figures underscore the sensitivity of the global beverage market to regional economic conditions and consumer behavior shifts, especially in large and influential markets like China and Brazil.
Despite the overall volume and revenue setbacks, AB InBev demonstrated regional variances in its performance. Revenue in China saw a substantial 6% decline, with volumes falling by over 7%. Similarly, Brazil experienced a nearly 2% drop in revenue and a 6.5% decrease in volumes. However, the company observed growth in all other global markets. Notably, U.S. revenue rebounded with a 2% increase, recovering from a 5% decline in the first quarter. This regional resilience, coupled with the company's strategic vision, has led CEO Michel Doukeris to express continued confidence in achieving the 2025 financial outlook, despite the prevailing dynamic operating environment.
The varied performance across different regions highlights the complex operational landscape for a global beverage giant like AB InBev. While the significant downturns in China and Brazil impacted the overall quarterly results, the positive growth observed in other markets, including a recovery in the U.S., suggests a geographically diverse demand base. CEO Michel Doukeris emphasized that despite the "dynamic operating environment," the consistent execution of the company's strategy in the first half of the year provides a strong foundation. This strategic consistency reinforces their conviction in meeting the previously set financial targets for 2025. The company's ability to adapt and perform in diverse markets will be key to its continued success and recovery from recent challenges.